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Abstract
X-linked Kallmann syndrome (KS) is a genetic disease that is caused by loss-of-function
mutations in the human kal-1 gene. The disorder consists of a loss of sense-of-smell coupled
with failure to undergo spontaneous puberty. At the cellular level, KS phenotypes are caused by
olfactory neurons’ failure to properly migrate to the olfactory bulb. This also prevents
gonadotropin-releasing hormone neuroendocrine cells from migrating to the pituitary,
preventing the pulsatile release of sex hormones at puberty. While many kal-1 interacting
proteins have been studied in model organisms, little is known about the regulatory
mechanisms that control kal-1’s expression. Since a 5.27kb promoter is sufficient to rescue lossof-function defects, we hypothesized that most of the kal-1 control elements are contained in
this region. In order to address our hypothesis, a lineage of P-kal-1-GFP was produced to
determine the cell-specific expression pattern. Using a promoter deletion assay the location of
tissue-specific enhancers was determined. In addition, a transcription factor candidate gene
screen was performed in which a single transcription factor, cnd-1, was found to regulate kal-1
with variable penetrance. From this we hypothesized that the regulation would be cell
autonomous. As such, cnd-1 loss-of-function mutations may have similar embryonic
phenotypes as kal-1 and could involve other, intermediate transcription factors. A coexpression assay found that the regulation of kal-1 by cnd-1 was cell autonomous. Using an
embryonic lethality assay and timing gastrulation cleft duration, cnd-1 loss-of-function was
found to have synergistic lethality with mutations in the efn-4 gene, similar to those seen in kal1, although they did not obviously affect neuroblast migration and gastrulation cleft duration.
To identify additional regulatory targets of cnd-1, we performed a comparative transcriptome
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of embryonic gene expression. No potential transcription factor intermediates or other
nematode orthologs of Kallmann syndrome genes were found to be differentially expressed in
the transcriptome with a q-value of less than 0.05. The transcriptome suggested that cnd-1
regulation covered a variety of pathways including ubiquitination and synaptic vesicle control.
Finally, this thesis details the beginning of a new endeavor to determine if CND-1 interacts with
the kal-1 regulatory region in a direct manner.
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Chapter 1 – Background
Accurate control of gene expression is fundamental for the development and function of
the central nervous system (CNS). Defects in CNS gene expression underlie many
neurodevelopmental disorders, indicating a critical need for further study. In order to
understand and potentially manipulate CNS gene expression, one must understand how it is
regulated. Gene expression is controlled by transcription factors that bind to the regulatory
regions of a gene, coupled with chromatin modifiers that regulate the chromatin architecture
around that region of a chromosome. To relate findings back to humans, many labs typically
use mammalian models such as mice; however, these models have relatively complex neuronal
systems. As an example, mice have approximately 70 million neurons and heterogeneity in their
number and distribution (Herculano-Houzel et al. 2010).
The nematode Caenorhabditis elegans is a simpler model, with an invariant cell linage
totaling 302 neurons. Differentiation in cell fate between individuals can thus be attributed to
genetic alteration rather than the heterogeneity of individuals (Sulston and Horvitz 1977).
Changes in cell fate and gene expression can also be easily visualized since the animals are
transparent. This transparency allows one to track cell lineages and gene expression through
the use of GFP reporters and 4D Nomarski microscopy. Culturing large amounts of worms is
convenient due to self-fertilizing hermaphrodites making up a majority of the population
coupled with the short generation time of three days to mature into gravid adults. This thesis
seeks to use C. elegans to uncover the gene regulatory network (GRN) that controls kal-1 by
examining the role of transcription factors and cis-regulatory elements affecting kal-1
expression.
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The kal-1 gene codes for anosmin-1, a secreted protein that contains Whey Acid Protein
(WAP) and cysteine protease inhibitor domains as well as four fibronectin type-III (FNIII)
repeats. Anosmin-1 is known to regulate neural branching and cell adhesion (Soussi-Yanicostas
et al. 1998). Humans with a mutation in this gene suffer a developmental defect called
Kallmann syndrome (KS). KS patients lack the neural connections required for the delivery of
gonadotropin-releasing hormone (GnRH) and have a significantly reduced or absent sense of
smell (Layman et al. 2013). Symptoms for this disease typically include stunted growth of
secondary sexual characteristics which is typically treated with GnRH supplements (Büchter et
al. 1998). Thus, there is a need to diagnose this condition early in order to properly address
developmental deficiencies during childhood and puberty. One clinical study was able to treat a
one-month old child with KS, restoring development of testicle and penis growth to that normal
for the child’s age (Sarfati et al. 2015).
In humans, kal-1 has been observed to play a role in processes other than neurological
development. A group of oral-maxillofacial scientists in China found that decreased kal-1
expression correlated with oral squamous cell carcinoma (Liu et al. 2015). kal-1 has also been
linked to dematomyocitosis and cell proliferation in the PC-3 prostate cancer cell line giving it a
broad spectrum of developmental and system roles (Raju and Dalakas 2005; Hu et al. 2004). In
addition, kal-1 loss-of-function has been found to cause renal and tooth agenesis along with
high arched palates (Dodé and Hardelin 2009).
kal-1 is highly conserved in C. elegans, to the point where the human Kal-1 cDNA can
both rescue kal-1 loss of function defects and cause the same gain of function phenotypes in C.
elegans (Rugarli et al. 2002). During embryogenesis, kal-1 plays a key role in ventral enclosure,
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where it allows for the proper shape and contacts between cells to occur. This takes place in a
different pathway than ephrin signaling and depends on interacting with the heparan sulfate
proteoglycans SDN-1 and GPN-1 (Hudson et al. 2006). Modifications to heparan sulfates are
known to regulate kal-1 binding in different contexts (Tecle et al. 2013). Murcia-Belmonte et al.
(2010) discovered that anosmin-1 and FGFR1 interact with one another through the FNIII and
WAP domains of anosmin-1. Recently, it was found that anosmin-1 forms a complex with FGFR
and L1 cell adhesion molecule (L1CAM) and that FGFR regulates the neurite branching activity
of kal-1 downstream through Ras signaling (Diaz-Balzac et al. 2015).
While kal-1 is an important gene in KS, there are 17 other loci identified as KS genes
(Kim 2015). Even so, 40% of patients with KS have no mutations in known disease loci,
indicating a large gap in our knowledge of what causes the condition (Layman et al. 2013). This
thesis seeks to determine the elements that regulate the expression of genes like kal-1. This will
help fill this gap in the literature and enhance our understanding of disease gene transcriptional
control.
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Chapter 2 – Identification of kal-1 Cis-Regulatory Elements

Introduction
Genetic regulation occurs on several levels in the central dogma of molecular biology.
Transcription factors play a critical role in gene regulation as DNA binding proteins that
promote or repress the transcription of genes to RNA. This is done in a number of ways
including promoting chromatin remodeling, blocking nucleosome repositioning, and
transforming the geometric tertiary structure of DNA (Spitz and Furlong 2012). Oftentimes
regulation is due to a combination of transcription factors functioning together, known as
transcriptional synergy. This could be due to a transcription factor complex binding to a specific
region or multiple bound transcription factors regulating the expression of a gene. In this sense,
transcriptional control could be likened to Boolean logic, where the activation of a gene may
require transcription factor A and B, A or B, or possibly A NOT B. Indeed, Boolean modeling of
transcriptional regulatory networks is a common systems approach to understanding
developmental processes and disease states (Akutsu et al. 1999; Dorier et al. 2016).
RNA processing in nematodes is characterized by a high propensity of trans-splicing. This
is a process in which the region between the transcriptional start site (TSS) and a trans-splice
acceptor (the outron) is removed and replaced by a short, 22 nucleotide, trans-spliced RNA
leader (Blumenthal 2005). In C. elegans, approximately 70% of C. elegans genes are transspliced (Allen et al. 2011). This type of transcriptional machinery allows for the use of operons
in nematodes, a transcriptional element that contains multiple genes. Within the C. elegans
genome, operons include approximately 15% to 17% of genes (Blumenthal et al. 2002; Allen et
al. 2011).
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The kal-1 gene is currently observed to be trans-spliced and not under the control of an
operon (Saito et al. 2013; Blumenthal et al. 2002). A 5.27Kb region upstream of the
translational start site is sufficient to rescue kal-1 loss-of-function phenotypes, suggesting that
most of the key kal-1 enhancer elements lie within this region (Bülow et al. 2002). A reporter
gene, otIs33, consisting of the same 5.27kb genomic region driving GFP, is expressed in mostly
neural tissue throughout the worm, including those documented in Figure 1. It should be noted,
however, that not all kal-1 expressing cells have been identified. Many otIs33 positive cells
within the head, ventral nerve cord, and tail are unidentified, most likely due to the high
density of candidate cells within that area (Bülow et al. 2002).
Known cellular expression of the otIs33 reporter
ASI – Head Interneuron
DVC – Tail Neuron
DVB – Tail Neuron
CAN – Canal Neurons
PVW – Posterior Interneuron
AIY – Head Interneuron
Ventral Nerve cord
PDB – Posterior Neuron
PVM – Posterior Ventral Microtubule Cell
HSN – Hermaphrodite Specific Motor Neurons
RID – Head Neuron
Uterine Muscle Wall
Figure 1. Known anatomy of kal-1 GFP expression in hermaphrodite C. elegans. List is created with data from Bülow et al. 2002.
Right image is from a stage 1 larva (L1) with an otIs33 reporter background. Image taken on Axioimager M2.

The cis-regulatory architecture governing the expression of kal-1 is also poorly
understood. Within a regulatory region of a gene there are typically multiple areas that govern
tissue-specific expression. While the specific elements controlling kal-1 have yet to be explored,
general promoter deletion assays and fluorescent reporter constructs have been made. In
addition to the 5.27kb otIs33 reporter, there was a 4.3kb reporter created and scored by
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Rugarli et al. (2002). A promoter deletion assay was also conducted by Wenick and Hobert
(2004) where they sought to identify the binding site of a specific transcription factor, ttx-3.
Based on their findings, regulation for only a few kal-1 expression cells have been identified
(Figure 2).
Reporter Name
Rugarli Reporter

Length
4.3kb

Reporter AΔbs

5.27kb

Reporter B
Reporter C
Reporter D
Reporter E

1.57kb
0.81kb
1.31kb
1.55kb

Reported Expression
CAN, Sensory Neurons,
HSN, PDB, PVW, EF3
(Male), tail neurons,
anterior ganglia, +
CAN,RID,AIZ,DVB,HSN
Uterine Muscle,+
Embryonic,+
HSN,DVB,+
+
AIY,+

Reporter F
0.32kb
AIY,+
Reporter G
0.27kb
AIY,+
Figure 2. Current understanding of kal-1 regulatory region. A (+) indicates expression in unidentified or unscored neurons. The
blue construct and corresponding data is from Rugarli et al. 2002 and the red ones are from Wenick and Hobert 2004.

Understanding the cis-regulatory architecture of kal-1 provides unique insights into
potential upstream genetic regulators and timing mechanisms. For example, a promoter
deletion assay might indicate that a region enhances expression in a certain tissue. This would
indicate that the transcription factors required must be both co-expressed in that tissue and
bind to that specific site. If expression data has a time component, then it allows one to further
narrow down regulating factors if they are expressed before the onset of gene expression.
Currently, only two transcription factors are known to regulate kal-1: the homeodomain
proteins LIM-4 and TTX-3 (Tsalik et al. 2003; Wenick and Hobert 2004). LIM-4 is mainly
expressed in neurons and plays a role in neuronal differentiation, locomotion, and food
searching behavior (Sagasti et al. 1999). Its regulation of kal-1 results in a 65% penetrant
defective expression in RID motor neurons of the otIs33 reporter, indicating that it is not solely
required for kal-1 expression (Tsalik et al. 2003). While there is no experimental evidence for
11

direct LIM-4 binding to the kal-1 promoter, multiple binding sites in this regulatory region are
predicted as potential LIM-4 sites (Weirauch et al. 2014).
Not only is ttx-3 mainly expressed in the AIY interneuron during adult stages, but it also
exhibits muscle expression in embryos and young larva (Hobert et al. 1997). It is involved in a
signaling cascade to control AIY development and function (Altun-Gultekin et al. 2001). Wenick
and Hobert (2004) were able to identify a 16bp TTX-3 specific binding site 56bp 5’ to the kal-1
translational start site that was required for kal-1 expression in the AIY neurons. With only two
known regulators of kal-1 explaining a small portion of its expression, much of the tissuespecific expression remains unexplored.
Public high-throughput chromatin immunoprecipitation sequencing (ChIP-seq) indicate
that there are multiple transcription factors that bind to the 5.27Kb regulatory region during
various life stages of the nematode (Araya et al. 2014). While this does not indicate the role
these transcription factors play in regulation, they do show that there are other transcription
factors binding to the kal-1 regulatory region. In addition, the binding sites of basic helix-loophelix (bHLH) proteins in C. elegans have been well characterized via high-throughput yeast-2hybrid assays (Grove et al. 2009). Together, these data give support to the idea that there are
other transcription factors involved in regulating kal-1 transcription.
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Figure 3. Representation of the kal-1 gene and potential cis-regulatory machinery. A) The sequence conservation of kal-1
between C. elegans and other nematode species. High conservation is observed within the outron and first intron of the gene.
Visualization from the UCSC genome browser (http://genome.ucsc.edu) B) Transcription factor binding sites based on GFP ChIPseq data from Niu et al. 2011. A sample of the transcription factors that bind to the kal-1 regulatory region at various points in
C. elegans development. C) Predicted bHLH binding sites based of a previously published interactome dataset (Grove et al.
2009). Binding sites of target transcription factors cnd-1 and hlh-10 are highlighted. All HLH-2/CND-1 binding sites also act as
HLH-10/HLH-2 binding sites as well.

The above literature search and preliminary data bring us to the following hypothesis:
kal-1 tissue-specific expression is controlled through cis-regulatory elements scattered
throughout the 5.27kb regulatory region. To explore this hypothesis, it is first necessary to
understand what cells express kal-1 and how it is controlled in the first place. To identify kal-1
reporter gene expression using confocal micrograph images alone is quite difficult even though
the neural system of the worm is fully mapped. One unbiased approach to this conundrum is to
take advantage of the invariant cell lineage of C. elegans and lineage the reporter. This has
been done successfully by groups such as the Waterston and Murray labs (Bao et al. 2006;
Zacharis et al. 2015). An additional benefit to this approach is that the lineage not only
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documents terminal cell fates, it also provides a timeline for embryonic gene expression that
could illuminate the temporal control of a kal-1 expression.
Tissue-specific expression is typically controlled by specific enhancer sites within the
promoter of a gene. The results from the Wenick and Hobert (2004) promoter deletion
experiment demonstrated the site specificity of AIY kal-1 expression but were analyzed in an
AIY-specific manner. In order to further analyze where additional potential transcription factors
might bind, it is critical to perform a generalized promoter deletion assay to detail which
components of the promoter control specific aspects of kal-1 expression. By dividing the
promoter into different regions, it should be possible to associate predicted binding sites or
public ChIP-seq data to where differential kal-1 expression occurs.
In order to screen for transcription factors that might affect a gene’s transcription, a
genetic analysis is typically done where there is a reporter for the gene and the transcription
factor is knocked out. In C. elegans, fluorescent reporters are useful due to the transparency of
the worm, the availability of transgenic animals from resources like the Caenorhabditis Genetics
Center, and the relatively short time to construct transgenic animals. Perturbation assays using
GFP reporters can be performed either by crossing a loss-of-function mutant into the reporter
or by using RNA interference (RNAi). The process of RNAi involves dsRNA inhibition of gene
expression via a RNA-induced silencing complex (Mohr et al. 2010). In nematodes, this type of
screen can be performed not only by injections, but also by feeding them dsRNA producing E.
coli or soaking them in a dsRNA containing buffer (Tabara et al. 1998; Timmons and Fire 1998).
The main hindrance with this method is that nematode neurons are resistant to RNAi methods
(Kennedy et al. 2004). Thus, for this particular screen the genetic analysis is preferable.
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Methods
kal-1 Expression Lineaging
A lineaging strain was constructed by crossing otIs33 [P-kal-1-GFP] with ujIs113 [pie1::mCherry::Histone H2B; Pnhr-2::mCherry::HIS-24; unc-119(+)], keeping the nematodes away
from light sources in order to minimize histone fluorescence. Embryos were mounted based on
the bead mounting method from Murray et al. (2006) and 4D timelapse videos were taken with
a Zeiss LSM700 or Leica SP5 confocal microscope. Starrynite (Bao et al. 2006) was used for cell
lineage tracing and Acetree (Boyle et al. 2006) was used to analyze and curate a GFP expression
cell lineage.
Promoter Deletion Assay
A GFP plasmid with the kal-1 promoter (otIs33) was graciously gifted by Hannes Bulow.
Fragments from the plasmid were created using a Phusion Hot Start PCR with an initial melting
temperature of 98oC for 10 seconds, an annealing temperature of 52oC and an extension
temperature of 72oC. Table 1 indicates the primers and annealing times specific to Reporters A
through C. For Reporter D, a HindIII dropout from the otIs33 plasmid was performed. A mixture
of PCR product, co-injection marker, and pBSII (+) was injected into the gonad using an Olympus
IX50 inverted microscope and Tritech microinjection system. P-ttx-3::RFP co-injection markers
were used for Reporters B and C while pCoel::GFP was used for Reporter A and D. Worms were
then placed on individual plates and offspring were checked for the presence of fluorescence
marker genes.
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Transgenic Forward Primer
Reverse Primer
Strain
Reporter A ACGACCTGTATCTTGATCC
ACAGTTATGTTTGGTATATTGG
Reporter B TTAGCGAATCCGCTGA
ACAGTTATGTTTGGTATATTGG
Reporter C ATGAGCGTTCTTCTCGA
ACAGTTATGTTTGGTATATTGG
Table 1. Primers, annealing time, and co-injection marker specific to each built reporter.

Annealing Time
(seconds)
79
60
50

Co-injection
Marker
pCoel::GFP
ttx-3
ttx-3

Candidate Gene Search
Candidate transcription factors were chosen based on the following criteria:
•
•
•
•

ChIP-Seq binding sites in the kal-1 promoter region
The conservation of those sites amongst nematodes
The overlap in expression with kal-1 based on the literature available
For bHLH proteins the availability of appropriate E-boxes based on the promoter
sequence.

For analysis, genes from this list were chosen only if a loss of function mutant met the following
conditions:
•
•

Does not cause embryonic lethality
Is available to order through the CGC, another lab, or we already have the strain in
storage

The ChIP-Seq data was viewed from the genome browser on wormbase.org from Niu et al.
(2011). Conservation of the promoter region between nematodes was done using the UCSC
genome browser tool (Kent et al. 2002). The bHLH interactome data in C. elegans was taken
from the Grove et al. (2009) study.
Transcription factor Loss-of-Function Analysis
Loss of function mutations for candidate TFs that could control kal-1 expression were
crossed into otIs33[P-kal-1-GFP] to produce double mutants. Worms were imaged at different
developmental stages using a Zeiss LSM 700 confocal microscope or AxioImager M2
epifluorescence microscope. Embryos were mounted onto microscope slides using the bead
mounting method from Murray et al. (2006) with the exception of a novel needle design for
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acquiring large amounts of embryos. Normally, a needle is formed by pulling a glass capillary
tube that is heated in the center to produce the needle, which is then attached to tubing. When
imaging multiple embryos, one typically organizes them with an eyelash brush and then adds
the coverslip to the slide. Because the bead mounting solution is viscous due to using methyl
cellulose, embryos did not move well with an eyelash brush. Instead, a wire was placed inside
of the needle up to the mouth so that embryos would stop at the wire and stick to one another
(Figure 4). The result is a brushless method for assembling large numbers of embryos in one
area.

A

B

Figure 4. Modified wire-needle for embryo extraction in methyl cellulose bead mounting. A) Full image of the needle, which
consists of a pulled capillary tube with a blunt wire inside that is secured by electric tape. The needle is secured in a pipette tip
that can easily be placed into tubing to form a mouth pipette. B) Image of the needle under magnification. The wire acts to stop
embryos from entering into the needle and causes them to stick to one another as they collide.

Larval and adult worms were mounted by placing them onto 2% agarose pads, adding
3µl of 10mg/ml sodium azide solution, and then placing a cover slip gently onto the pad.
Because sodium azide can degrade the GFP signal in neurons over time, worm mounts were
only imaged for 20 minutes after the addition of sodium azide. Samples were compared to one
another for differential fluorescence to determine the effect of the candidate TF mutation on
kal-1 transcription.
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Results
Embryonic Lineage of kal-1
An embryonic lineage of kal-1 gene expression was obtained up to the 384 cell stage
(Figure 5). The lineage represents the initial set of cells that first turn on kal-1 expression. Cells
reported in the lineage have terminal cell fates consistent with the types of cells that display
kal-1 GFP expression and include novel identifications of kal-1 expressing cells. Expanded
images can be found in Supplementary Figure 1.

Figure 5. The embryonic lineage of kal-1 gene expression as a tree representation. The color indicates relative levels of
expression with red being very high expression and purple being no expression. Time-lapse videos were analyzed using
Starrynite and Acetree. Expanded images can be found in Supplementary Figure 1.

Of the kal-1 expressing cells in the lineage, 73 were identified out of a total of 384
(Table 2). Assuming the terminal cell fates of these precursors all express kal-1, a total of 110
terminal cells were identified with 106 of them being novel identifications. The terminal cell
fates suggest that kal-1 initially turns on in many sensilla precursors and then turns on in head
and tail neurons along with cells in the pharynx, hypodermis, body wall muscle and gut. From a
lineage perspective, only the Z, D, C, and E lineages did not show kal-1 expression.
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Sensilla

Head
Neurons
(Posterior
Axons)
ALA

Head
Neurons
(Ring)

Pharynx

Nerve
Cord

Hypodermal
and Body
Wall Muscle

Gut

Tail
Neurons

Other

CEPshDR/L

Head
Neurons
(Anterior
Axons)
BAGL

AIYR/L

e3VL

DA6

hyp 3 (2)

B

DVA

CANR

CEPsoVR

RIPR

AVAL

RIH

g1AL

DA7

hyp 8/9

exc_cell

LUAR

IL1VL

URBR/L

AVBR/L

RIS

pm2VL

DA9

hyp10 (2)

F

PDA

IL2

URYDR/L

AVDR/L

RIVR/L

pm4VL

DB4

mu_bod (3)

mu_anal

PHAR

IL2VL

AVER/L

pm5VL

mu_int_L

PHshR/L

ILshDR/L

AVHR

RMDVR/
L
RMEL

pm7VL

mu_sph

PVCR

ILshR/L

AVL

rect_VR/L

PVPR/L

ILshVR/L

REML

U

AINR/L

ILsoDR/L

RID

ILsoR

RMED

ILsoVR/L

RMEV

OLLL

SAADR/L

OLLshR/L

SIADR/L

OLLsoR

SIBVR/L

OLQDL

SMDDR/L

OLQshSR

SMDVL

OLQshVR/L
OLQsoDR/L
OLQsoVL
AMshR/L
AMsoR
Table 2. Categorization of inferred terminal cell fates from the otIs33 lineage. The majority of cells are one cell division away
from terminal cell fates. A (/) indicates a pair of neurons. The full list of precursor cells is given in the supplementary Table 4.

Promoter Deletion Assay
Transgenic animals were analyzed in both embryonic development and in adult stages.
Animals were scored for cellular expression in readily identified cells. Expression of GFP from
the extra-chromosomal array varied among individuals. Several exceptions can be seen,
however, including the DVB/C neurons expressing GFP in Reporter C but not B or D and the
HSNs being found in Reporter D and A but not B and C. Cellular expression was attributed to a

19

reporter if it was scored more than once. Figure 6 outlines the expression patterns among
reporters.
Reporter Name
Reporter A

Length
3.33kb

Reporter B

2.09kb

Reporter C

1.43kb

Reporter D

.32kb

Expression Pattern
AIY, AIZ, ASI, RID,
ILL/OLL, CAN, HSN,
PVM,PDB,PVW,DVB/C,
PVP, Gut, VNC Neurons
AIY, AIZ, ASI, PVM, PVW,
PVP, Gut
AIY, AIZ, ASI, PVM, PVW,
DVB/C, PVP, Gut
AIY, AIZ, ASI, HSN, PVM,
PVW, PVP, Gut

Figure 6. kal-1-GFP promoter deletions and reported expression. Cells were only reported if they were scored more than once.

The scoring of individuals identified the cis-regulatory control regions of several
neurons. Expression in the 320bp Reporter D showed expression in the Gut, AIY, AIZ, ASI, HSN,
PVM, PVW, and PVP. With the exception of the HSNs, this expression pattern is carried through
Reporter C and B until new neurons appear in Reporter A. The scoring done in Table 3 indicates
only the most easily identifiable cells. As such, this is only a subset of total kal-1-GFP expression

Total Scored

AIY

AIZ

ASI

RID

M5

ILL/OLL

CAN

HSN

PVM

PDB

PVW

DVB/C

PVP

Gut

VNC Neurons

and is not a comprehensive list.

Reporter A

37

36

23

13

10

1

28

8

10

5

27

13

33

8

37

6

Reporter B

23

20

12

5

0

0

0

0

0

4

0

7

1

4

23

0

Reporter C

29

26

15

13

0

0

0

0

0

4

1

10

3

4

27

0

Reporter D

23

21

18

8

0

0

0

0

2

4

1

3

1

8

23

0

Table 3. Promoter deletion assay of the kal-1-GFP reporter in post-embryonic nematodes. Reporters are extrachromosomal
arrays and thus the animals are chimeric.
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Analysis of Candidate kal-1 Transcriptional Regulators
ChIP-seq and predicted bHLH binding sites in the kal-1 promoter region were used to
identify a list of candidate TF genes that may control kal-1 transcription (Grove et al. 2009). Of
the identified candidates, 7 genes were tested based on the availability of a knockout strain.
Embryonic kal-1 expression was examined for the first 360 minutes into development (pre-bean
stage) using confocal microscopy time-lapse videos. Larva and adult expression differences
were limited to only identifiable neurons and do not include the comprehensive list of cells
obtained from the lineage. Table 4 outlines the results of this analysis and indicates differential
expression was found in one TF knockout, cnd-1(ju29).
Transcription Factor

Loss of function allele

Differential
Expression Embryo

Differential
Expression L1 Larva

Differential Expression
Adult

ALR-1

ok545

N

N

N

CEH-14

ch3

N

N

N

CND-1

ju29

Y

N

N

EOR-1

cs28

N

N

N

HLH-10

ok576

N

N

N

MDL-1

tm311

N

N

N

NGN-1

ok2200

N

N

N

Table 4. An examination of differential GFP expression based on mutants with the otIs33 reporter and a loss of function for
different transcription factors. Expression is reported with a “N” for no differential expression observed and a “Y” for observed
differential expression.

For cnd-1 loss of function embryos, a change in kal-1-GFP expression was found in the
anterior portion of the embryo beginning around 280 minutes into development. Loss of the
GFP reporter in cnd-1(ju29) backgrounds was variable between individuals. The detailed
examination of kal-1-GFP expression in a cnd-1(ju29) mutant background will be highlighted in
the co-expression assay on chapter 3.
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Discussion
kal-1 Expression and Potential Enhancer Sites
From the analyses performed, the results suggest that kal-1 has complex and robust
regulation. While its currently known functional roles have been described in neurons, it is also
expressed in some non-neuronal tissues and also shows expression in some MS lineage cells.
Previous studies in humans also demonstrated non-neuronal kal-1 expression; hence, this
expression data is not surprising, though it certainly leaves open the question of what the
specific role of kal-1 is in these cells.
Lineaging the embryonic expression of kal-1 has yielded novel insights into expression
patterns, revealing previously unidentified cell-specific detail. One example is found in the
strong, initial expression of the reporter in many sensilla-related neurons. The sensillum is a
sensory organ in nematodes that allows it to perceive chemical, temperature, pheromone, and
mechanical sensations (Figure 7; Altun and Hall 2010). While it was known that kal-1 was
expressed generally in this system, the embryonic lineage details the extent of kal-1 expression
within this system. The sensilla system is comprised of six different types of cells: amphid,
cephalic, inner labial, outer labial, deirid, and phasmid. This new data indicates that expression
occurs in some capacity in all except for deirid sensilla, forming the basis for future analysis of
kal-1 function in these cells.
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Figure 7. Overview of the sensillum. A) Anterior diagram in the head, including the cephalic, inner and outer labial, and amphid
sensilla. B) Whole view diagram including the deirid and phasmid sensilla. Neurons are labeled such that amphid neurons begin
with “Am”, inner labial with “IL”, outer labial with “OL”, and cephalic with “CEP”. Figure from Worm Atlas (Altun et al. 2010)

When examining the onset of P-kal-1-GFP expression, the lineage reveals that aside
from the initial anterior sensilla cells, most of the other cells in the embryo turn on kal-1-GFP
expression around the same time. In addition, daughter cells of P-kal-1-GFP expressing cells
seem to also express the transgene without subsequently turning off the expression later in
development. This lends credence to the assumption that the expression pattern of kal-1 is
stable throughout development, although a lineage further along in development is necessary
to demonstrate it.
One explanation for the expression pattern of kal-1 in Reporter D is that it overlaps one
of two highly conserved regions within the 5.27kb regulatory region (Figure 8). The conserved
region covers approximately 269 bases from the first exon and is known to include the AIY
enhancer (Wenick and Hobert 2004). This site may also control regulation in other tissues,
although further experimental analysis is required. As an alternative explanation, Reporter D
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might not actually control that much expression relative to Reporter B and C but may be scored
as such due to the limitations of the scoring methodology. An unbiased and more
comprehensive solution would be to integrate the reporter lines into the genome and lineage
them, though this would require a significant time investment.

Figure 8. Positions of reporters compared to areas of high conservation among nematode species. The black bar indicates
distance from translational start site with numbers representing distance from the transcriptional start site in base pairs. The
red bar indicates where each transgenic reporter is located concerning novel tissue-specific expression (e.g. if a cell is found in
Reporter C but not D then its corresponding cis-regulatory element would be in Region C). Green bars indicate areas of high
conservation among nematodes.

Three ChIP-seq binding sites of the following transcription factors fall within the
promoter region of Reporter D: mep-1, nhr-6, and mab-5. Currently, there is little detailed
expression data to know if nhr-6 is co-expressed in Reporter D expressing cells. For mab-5, coexpression occurs in the gut but is not known to be co-expressed in other tissues (Sarov et al.
2012). mep-1 does have co-expression in Reporter D specific precursor cells except for PVPL/R;
however, it is ubiquitous in the worm and currently has no known neuronal-specific functions
(Belfiore et al. 2002).
In comparison to the kal-1-GFP reporter genes found in previous literature, this data
generally matches their observations (Rugarli et al. 2002; Wenick and Hobert 2004). One
interesting case is in the HSNs, which appear in Reporter A and D. One explanation for why the
HSNs could be found in Reporter D is that there is cis-regulatory architecture found within
Reporters B and C that repress the site found in D. Of course, only very few instances of HSN
were reported for D. It is entirely possible that the expression pattern could be due to a
mutation or defect in the animal, though the worms scored appeared wild-type. For the
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enhancer site of HSN specific expression, and using the data from Wenick and Hobert (2004),
one can narrow down both the HSN and DVB specific enhancer sites to an approximate 465bp
location in the upstream portion of the reporter (Figure 9).

Figure 9. Location of the HSN and DVB cis-regulatory element. The blue bar represents the region covered by Reporter C in the
Wenick and Hobert (2004) paper while the yellow bar indicates the overlap between that it and Reporter A. This overlapping
region is most likely where the cis-regulatory element for the HSN and DVB neurons is located.

Out of the current ChIP-seq data publicly available, only the transcription factor lin-13
binds to this region. This gene is expressed in multiple neurons and is known to function in
vulval developmental cell fate specification (Meléndez and Greenwald 2000). The embryonic
lineage of lin-13 also indicates high expression in precursor cells for HSNL/R: ABplappa and
ABprappa (Murray et al. 2012). Using predicted binding sites, a compiled a list of potential
transcription factors that are both co-expressed with kal-1 and are predicted to bind to the
HSN/DVB enhancer can be found in Table 5.
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Gene

Binding Evidence

Binding Sites

Co-expression Evidence

B0310.2

Motif Prediction

1

EPIC Database

ceh-20

Motif Prediction (+)

8

Wormbase

die-1

Motif Prediction (+)

1

EPIC Database

egl-27

Motif Prediction

1

EPIC Database

egl-43

Motif Prediction

1

Wormbase

elt-1

Motif Prediction (+)

5

EPIC Database

elt-6

Motif Prediction

1

EPIC Database

F23F12.9

Motif Prediction (+)

2

EPIC Database

hlh-3

Y2H

1

Wormbase

hlh-14

Y2H

1

Wormbase

lin-1

Motif Prediction

1

EPIC Database

lin-13

ChIP-seq

1

EPIC Database

lin-14

Motif Prediction

2

Wormbase

unc-86

Motif Prediction

1

Wormbase

Table 5. Predicted transcription factors that are co-expressed and predicted to bind to the HSN regulatory region for kal-1.
Motif prediction done using CIS-BP prediction tool (Weirauch et al. 2014). A (+) symbol is added to motif prediction genes if the
score of at least one binding site of the gene was in the top 10% of scores given. Yeast two-hybrid (Y2H) binding evidence is
th
from Grove et al. 2009. Databases searched June 4 2017 (Wormbase: wormbase.org; EPIC Database: epic.gs.washington.edu).

Candidate Gene Screen for Transcription factors that alter kal-1-GFP expression
A transcription factor screen was conducted to determine if predicted genes interacted
with kal-1 based on ChIP-seq and bHLH interactome data. Only cnd-1(ju29) mutants were found
to disrupt or enhance kal-1 expression. Expression changes were noted in the anterior portion
of the embryo and the degree of change seems to vary from sample to sample. Potentially, this
could indicate that the interaction between cnd-1 and kal-1 is influenced by other transcription
factors in the form of a sub-network of genes. Differential expression solely in the embryonic
stage could either be a product of limited scoring capabilities in larval nematodes, expression in
those cells is recovered later on in development, or the regular expression of kal-1 in those cells
decreases or turns on later in development. While the data itself does not indicate if the
differential expression is direct or not, lineaging data from the EPIC database does indicate co-
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expression with kal-1. Chapter 3 details further investigation into the role this transcription
factor plays in regulating kal-1 expression.

27

Chapter 3 – CND-1 Regulation of kal-1

Introduction
In the previous chapter, a transcription factor screen was performed in order to identify
novel regulators of kal-1. Out of the seven transcription factors analyzed, only one showed
differential kal-1-GFP expression, cnd-1. In this chapter, the role cnd-1 might have in the
context of kal-1 regulation and as a potential KS gene itself is explored.
NeuroD1, the mammalian ortholog of cnd-1, is a bHLH protein involved in neuronal cell
fate specification. Patients with NeuroD1 loss of function have been diagnosed with visual
impairment, learning disabilities, deafness, and neonatal diabetes (Rubio-Cabezas et al. 2010).
NeuroD1 plays an active role in human anterior pituitary development, where it is involved in
the control of Pro-opiomelanocortin, a precursor peptide that functions in hormone production
(Davis et al. 2013). In addition, NeuroD1 has also been observed to be up-regulated in pituitary
cortitroph adenomas (Seltzer et al. 2015). In rodents, NeuroD1 has been shown to play critical
roles in olfactory epithelium and olfactory receptor neuron fate specification (Kam et al. 2014).
Loss of function both prevents maturation of neurons in the olfactory bulb and reduces their
number (Boutin et al. 2010).
Within the context of Kallmann syndrome, NeuroD1 has been reported to regulate
multiple KS genes. A study by Cherrington et al. (2008) showed that NeuroD1 regulates GnRHR
in mice and identified the specific E-box utilized by the transcription factor. Within a mouse cell
culture setting, Pataskar et al. (2015) obtained a transcriptome of NeuroD1 gain-of-function
embryonic stem cells which identified Sema3A, Chd7, and ProkR2 as differentially expressed.
One other KS gene that may be regulated by NeuroD1 is FGF8. Research done by Jahan et al.
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(2015) shows that in the organ of Corti in mice, a loss-of-function of NeuroD1 will cause FGF8
mis-expression and when combined with a heterozygous Atoh1 mutation causes significant
reduction in FGF8. These data, coupled with the finding that cnd-1 may regulate kal-1, provides
supporting evidence that NeuroD1 functions in multiple aspects of the KS disease system.
In C. elegans, cnd-1 is expressed in many AB lineage neurons in the head and ventral
nerve cord along with some MS lineage cells (Murray et al. 2012). Currently, little is known
about the role of cnd-1 outside of the ventral nerve cord. Only three genes are known to act
downstream of cnd-1 in C. elegans: unc-3, unc-4, and unc-30. All three genes are transcription
factors that are co-expressed with cnd-1 in D class motor neurons. It has been shown that
NeuroD1 is required to dimerize with another protein as it is unstable in its homodimeric form
(Longo et al. 2008). While it has been shown that CND-1 does bind to HLH-2, yeast-two-hybrid
assays have shown that it also interacts with ZTF-2, UNC-62, and MDT-11, although it is not
known what their function might be in vivo (Reece-Hoyes et al. 2013). A summary figure of the
global cnd-1 regulatory network is given in Figure 10.
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A

B

Figure 10. Transcriptional mCherry reporter and summary of the current gene regulatory network of cnd-1. A) Image of
mCherry reporter taken on a Zeiss LSM 700 confocal microscope. B) Three genes, unc-3, unc-4, and unc-30 are known
downstream targets, most likely by a CND-1/HLH-2 dimer (Hallam et al. 2000). Three additional proteins, ZTF-2, UNC-62, and
MDT-11, are also known to bind to CND-1 through yeast-2-hybridization assays, although their function in vivo is unknown
(Reece-Hoyes et al. 2013). Only genes one degree away from cnd-1 are shown.

In the context of the interaction of cnd-1 and kal-1, our perturbation assays indicated
that cnd-1 might interact with kal-1 during embryogenesis. However, such an assay does not
indicate if the interaction is direct or cell-autonomous. Within the 5.27kb region of the otIs33
reporter, there are three predicted binding sites for CND-1/HLH-2 based on the yeast 2
hybridization assays from Grove et al. (2009). If an assay shows that the regulation is non-cell
autonomous, it is likely that cnd-1 does not directly regulate kal-1 since it is a transcription
factor. Instead, it would be more probable that cnd-1 regulates signaling molecules that may
have downstream effects regulating kal-1 expression.
While previous lineage data on cnd-1 indicates that there are many cells in which cnd-1
and kal-1 are co-expressed, they do not sufficiently indicate if differential expression of kal-1
within cnd-1(ju29) worms occurs in co-expressed cells (Murray et al. 2012). As CND-1 is a
transcription factor which acts through direct binding, it leads us to the following hypothesis:
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CND-1 regulation of kal-1 is cell autonomous. One way of tackling this problem is through a coexpression assay of fluorescent reporters for the genes. Having co-expression of reporters in a
ju29 background is possible using transcriptional reporters. They consist of the promoter
regions of the genes and drive expression of a fluorescent protein. Hence a major assumption is
that cnd-1 is regulated in a similar manner in a ju29 background, as a severe change in
expression pattern could obfuscate comparison of the control and experimental groups
While cnd-1 may regulate the expression of kal-1, it is currently unknown in what
functional capacity kal-1 is regulated. Embryonically, kal-1 is known to be involved in
gastrulation. In kal-1 loss-of-function mutants, the mean duration of the gastrulation cleft
increases from 55 to 80 minutes, indicating a defect in cleft closure (Hudson et al. 2006). This
defect increases synergistically in efn-4 (bx80) kal-1 (gb503) double mutants, suggesting the
two genes act in a parallel pathway (Hudson et al. 2006). Figure 11 details the process of
gastrulation cleft formation and closure.
Embryonic lethality of kal-1 (gb503) and efn-4 (bx80) mutants has also been reported as
synergistically lethal, though its correlation to gastrulation effects is not proven (Hudson et al.
2006). Because of cnd-1’s potential regulation of kal-1, the following hypothesis is proposed:
cnd-1 loss-of-function mutations cause phenotypes similar to kal-1 in embryonic development.
In order to determine if cnd-1 might cause kal-1 like embryonic phenotypes, one could
analyze the previously mentioned defects. Embryonic lethality and gastrulation cleft durations
were determined in the context of a parallel pathway with efn-4. If cnd-1 loss-of-function also
shows synergistic lethality and increased cleft duration, it would indicate that it acts in a similar
manner to kal-1. Understanding the relative stages at which cnd-1 might cause observed
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embryonic phenotypes would help determine a potential interaction with kal-1. For example,
lethality prior to the onset of kal-1 expression would rule out that phenotype being due to cnd1 regulation of kal-1.

A

B

C

D

Figure 11. The embryonic gastrulation cleft. A) MS lineage cells before ingression. B) A pair of MS lineage cells after ingression,
signaling the start of the cleft. C) The gastrulation cleft mid-way through the process. D) Time just after closure of the cleft.

Regulatory networks controlling gene expression are typically complex and tissuespecific. The regulation of a gene can involve sub-networks of transcription factors to govern
the timing of its expression and respond to stimuli from the environment. For example, a feedforward sub-network would involve at minimum two transcription factors and give stability
through redundancy in the gene’s expression. Because of the potential variation in CND-1
regulation of kal-1, it is entirely possible that it is involved in a complex regulatory network.
In addition to regulation of kal-1, cnd-1 may play a role in the regulation of other known
KS orthologs. Many KS genes are involved in olfactory and neuronal development in humans,
and could also be transcriptionally downstream of NeuroD1. As previously indicated, five genes
in the mouse model are known to be regulated by NeuroD1 in some fashion; hence, it is
possible that cnd-1 interacts with orthologs of KS genes in nematodes other than kal-1. Out of
the known 17 KS genes, approximately 10 have orthologs in C. elegans and are potential targets
for investigation (Table 6).
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KS Gene

C. elegans Ortholog

BlastP E-Value

Literature Evidence

Known NeuroD1 Regulation
in Other Systems

AXL

F11E6.8

6.00E-60

N/A

N

CHD7

chd-7

0.00E+00

N/A

Y

FEZF1

fezf-1

5.00E-96

N/A

N

FGF8

egl-17

**

Birnbaum et al. 2004

Y

FGFR1

egl-15

2.00E-130

Itoh and Ornitz 2004

N

HS6ST1

hst-6

3.00E-92

Bulow et al. 2002

N

SEMA3A

smp-1

6.00E-75

N/A

Y

SEMA7A

smp-1

5.00E-33

N/A

N

SOX10

sox-2

2.00E-29

N/A

N

WDR11

Y110A7A.9

3.00E-81

N/A

N

Table 6. KS genes with C. elegans orthologs other than kal-1. List created using NCBI BlastP.
** BlastP yields only the other FGF gene in C. elegans, let-756. Literature evidence suggests that egl-17 is orthologous to FGF8.

Because of the regulation of KS gene orthologs in mice by NeuroD1, it leads to the
hypothesis that: CND-1 regulates KS gene orthologs during embryonic development. To
comprehensively examine the effect cnd-1 has in gene expression, the assembly of a
transcriptome is required. Transcriptomes are a quantification of the transcribed RNA that can
represent gene expression. In C. elegans embryonic sequencing experiments, it is not
uncommon to see them gathered in broader stages such as “early embryo”, “late embryo”, or
“mixed stage embryos” due to the difficulty in staging them (Deng et al. 2006; Kirienko and Fay
2007; Liu et al. 2011). Hence, some noise would be expected in the dataset due to the variation
in developmental expression. Genes that are differentially expressed, however, would most
likely indicate those severely affected by the loss of CND-1 function throughout embryonic
development.
If cnd-1 and NeuroD1 are shown to regulate a total of six KS genes, then it becomes
critical to study the genomic regulation of NeuroD1 itself as a potentially novel KS gene. While
NeuroD1 has not been identified in genome wide association studies as a KS disease gene, its
effects on the development of the tissues involved in KS and the regulation of known KS genes
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means that it may play a critical molecular role in variants of the disease (Quaynor et al. 2016).
By understanding the systemic effects of cnd-1 loss-of-function it is possible to speculate in
which pathways cnd-1 functions in.
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Methods
Co-Expression Assay
otIs33[P-kal-1-GFP] and stIs10055[P-cnd-1-mCherry] were crossed together to form a
trans-heterozygous strain. otIs33 appears to map very close to stIs10055, as it proved
impossible to identify any recombinant chromosomes bearing both transgenes. cnd-1(ju29);
otIs33/+ +/stIs10055 was also built in order to compare differential kal-1 and cnd-1 expression
in a cnd-1 mutant background. Embryos were imaged using confocal microscopy and only those
with both red and green markers were selected for analysis.
Embryonic Lethality Assay
Plates were streaked with E. coli and on the next day stage 4 larval (L4) worms were
placed onto the plates, one per plate. Each day, the L4 worms were transferred to another
plate on one-day old food, and the embryos assessed for developmental arrest from the plates
from the previous day. The percentage of the brood that survived on each plate over five days
was calculated.
Gastrulation Assay
Embryos were dissected from gravid worms and mounted onto slides with a methyl
cellulose bead solution and sealed with petroleum jelly. 4D-timelapse movies ranging from 6 to
7 hours were taken using an AxioImager M2 with a 40x DIC objective. Embryos were only
scored if their ventral side was facing in an upright position.
Worm Culture and RNA Extraction
Worms with a cnd-1 loss of function mutation (ju29) and N2 wild-types were grown in
liquid cultures of M9 buffer supplemented with 1mg/ml cholesterol and fed with E. coli (OP-50).
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When the first generation of a population reaches a gravid, adult stage the culture is treated
with “death” buffer (1% NaOCl, 0.5M NaOH in water) in order to isolate embryos. This keeps
the population at the same stage of development and allows for large quantities of embryos to
be harvested in subsequent cultures.
Total RNA was extracted using a phase-separation method. Embryos are placed into
Ribozol in a 1:10 ratio, lysed with mild pipetting, and incubated at room temperature for five
minutes in phase-lock gel microtubules. The cell lysate is then centrifuged at 14,000 rpm for 10
minutes at 4oC and about 20% of the volume in chloroform is added. The vial is then shaken and
centrifuged again at the same settings for 15 minutes. At this stage, the inert gel in the phaselock tubes should serve as a barrier between the aqueous and organic phases. The aqueous
phase is transferred to a new tube and 500μl of isopropanol along with 3μl of glycogen is added
in order to precipitate the RNA and enhance pellet visibility respectively. After incubating for 10
minutes at room temperature, the sample is centrifuged at the same settings for 10 minutes.
The RNA pellet is visible and the supernatant is removed. Next, 100μl of 75% ethanol is added
and the sample is briefly vortexed and centrifuged for 5 minutes at 7500 RPM. After the
ethanol is removed the RNA is stored in diethyl dicarbonate (DEPC) treated water at -80oC.
RNA quality control was done in two steps. First, 2μl of each sample was analyzed using
a Thermo Scientific NanoDropTM Lite, which gives an estimated concentration and an
A280/A260 ratio indicating RNA purity. Next, the samples were analyzed at Emory University’s
Integrated Genomics Core for analysis using a Bioanalyzer to quantify any degradation of RNA
samples and assign a RNA integrity number (RIN). While minimum RINs for sequencing samples
have been debated, it is known that degraded RNA causes an artificial decrease in small gene
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expression detection and an increase in larger genes due to the differential impact degradation
has based on gene size (Romero et al. 2014). All samples used in transcriptome assembly had a
RIN number above 9.2 and were sent to the University of Kansas Genome Sequencing Core
where they were prepared using an Ovation Ultralow Library System v2 (NuGEN) and
sequenced with an Illumina HiSeq 2500 system. Sequencing was single ended with reads 101
base pairs in length.
Transcriptome Assembly
Quality control of raw sequence reads was performed using the GUI version of FastQC
(v0.11.4, Babraham Bioinformatics). The processing of read data into a transcriptome follows
the workflow from the Pertea et al. paper (2016). Sequences were aligned to the C. elegans
genome (WBcel235) using HiSAT2 (v2.0.4; Kim et al., 2015) as sam files, which were converted
to bam files using samtools (v1.3.1; Li et al., 2009). Stringtie (v1.2.4; Pertea et al. 2015) was
used to assemble the transcriptome and a python script from the supplemental material in
Pertea et al. (2016) was used to convert the results into count tables. These tables were used in
DESeq2 (v1.14.1; Love et al. 2014) on the Galaxy server (Galaxy Tool Version v2.11.38; Afgan et
al. 2016) in order to determine differential expression.
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Results
Co-expression Assay
otIs33/+ +/stIs10055 embryos were imaged under a confocal microscope and examined for
mCherry and GFP expression. Co-expression occurred in several places, mostly confined to the
anterior half of the embryo. Within the “pocket” of otIs33 expressing cells (indicated by the
white arrow) there are a group of cells that are co-expressed in wild-type but not in a cnd-1
(ju29) background. The extent of this differential expression varies between individuals but it is
within this group of cells that it occurs. Figures 12 and 13 gives an example of the differential
expression that occurs.

Figure 12. Co-expression assay of otIs33 and stIs10055. The green channel indicates otIs33 while the red indicated stIs10055.
Top row is in a wildtype background while the bottom is in a cnd-1 loss-of-function background. The white box and arrow
indicates the region of differential expression. Time is an approximation of minutes into development.
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A

B

Figure 13. Co-expression assay of otIs33 and stIs10055. A) Channel split comparison of both embryos. B) Scaled version of
differential expression. White arrows indicate specific cells that have differential GFP expression.

Embryonic Lethality
The embryonic lethality of wildtype, cnd-1, kal-1, efn-4, cnd-1; efn-4 and kal-1; efn-4
mutants were compared. An ANOVA indicated that genotype significantly affected embryonic
lethality rates (F = 49.375, p-value < 0.0001). A post-hoc pairwise t-test was performed and
determined that N2, kal-1 (gb503), and cnd-1 (ju29) are not significantly different from one
another while efn-4 (bx80), kal-1 efn-4, and cnd-1 enf-4 are (adjusted p-value < 0.05).
Embryonic lethality of cnd-1 and cnd-1; efn-4 mutants show similar trends to kal-1 and kal-1
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efn-4. By themselves, cnd-1 and efn-4 mutants showed low embryonic lethality at
approximately 2% and 11.6% respectively. When in a double-mutant background, synergistic
lethality was observed at approximately 20.4%. However, this was significantly lower than the
synergistic lethality observed in kal-1 enf-4 double mutants at 35.3% (Figure 14).

Figure 14. Embryonic lethality of multiple mutant backgrounds. N2, kal-1 (gb503), efn-4 (bx80) and kal-1 efn-4 data referenced
from Hudson et al. 2006. Groups labeled with a “N.S.” are not statistically significant from one another while those with a “*”
are. Statistical significance was determined using an ANOVA and a post-hoc pairwise t-test with a Bonferroni correction with an
adjusted p-value of less than 0.05. Error bars represent standard error of the mean.

Gastrulation Cleft Duration
Gastrulation cleft duration for wildtype, cnd-1, and kal-1 backgrounds were compared.
A two-way ANOVA showed that genotype had a significant effect on gastrulation cleft duration
(F = 27.70, P < 0.0001). A post-hoc pairwise t-test with a Bonferroni correction indicated that
each group was significantly different from one another with an adjusted p-value of 0.05.
Wildtype embryos showed an average of 55 minutes whereas kal-1 (gb503) mutants show an
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increased cleft duration averaging 80 minutes. Embryos in a cnd-1(ju29) background show a
decreased gastrulation cleft duration averaging 43 minutes (Figure 15).

Figure 15. Gastrulation cleft durations in N2, kal-1 (gb503) and cnd-1 (ju29) backgrounds. N2 and kal-1 (gb503) data referenced
from Hudson et al. 2006. All groups are statistically significant from one another as determined by an ANOVA and post-hoc
pairwise t-test with a Bonferroni correction. Error bars represent standard error of the mean.

Transcriptome Analysis
Embryos with a cnd-1(ju29) background were compared to wildtype with three
biological replicates of each. Individuals ranged developmentally from two-cell through to fourfold (pre-hatching) embryos. In total, 17 genes were found to be significantly down-regulated
and 10 genes up-regulated based on a q-value of 0.05 or less (Table 7). Out of these, 6 of them
are pseudogenes which produce transcripts but do not code for proteins. Of the 21 proteincoding genes, 15 of them (approx. 70%) are nematode specific, which was determined based on
a BlastP query.
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Up-regulated Genes

Down-regulated Genes

Gene

Fold Change

Q-value

Gene

Fold Change

Q-value

C04G6.10

2.689

4.17E-03

C08F11.7

0.252

7.64E-07

cnc-10

2.561

8.02E-03

C18H2.3

0.106

4.23E-21

F13E9.15

2.552

7.92E-03

C33E10.4

0.213

1.27E-08

F26E4.4

2.719

1.11E-03

C47G2.7

0.224

5.70E-08

F33E2.5

2.632

7.35E-03

F09G8.7

0.151

9.31E-14

F35B3.3

5.010

1.40E-09

F35B3.4

0.067

3.81E-31

fbxb-41

2.441

1.65E-02

fbxa-191

0.299

8.19E-05

lgc-34

4.649

8.74E-12

fbxa-192

0.410

1.41E-02

rpl-38

31.538

7.53E-71

fbxb-111

0.395

9.85E-03

Y57E12AR.1

2.662

7.92E-03

glb-1

0.178

8.74E-12

his-67

0.234

1.64E-07

K05F6.12

0.314

3.03E-04

srw-85

0.158

6.24E-14

T03F6.10

0.356

4.17E-03

ttr-33

0.348

2.41E-03

Y102A5C.5

0.306

6.36E-05

Y82E9BR.22

0.415

2.36E-02

Table 7. Differential expression of genes with statistical difference in the cnd-1 (ju29) transcriptome. The q-value reported is an
adjusted p-value for multiple corrections, also known as a false discovery rate.

When looking at the data from a broader viewpoint, with a p-value cutoff of 0.01, 97
genes are found to be differentially expressed. Of these, 78 have neuronal expression in the
same expression clusters as cnd-1 (Kaletsky et al. 2015; Spencer et al. 2011). A functional
annotation clustering in DAVID found four clusters from 68 of the genes: membrane
components, nucleotide binding, collagen, and reproduction and developmental functions
(Huang et al. 2008; Huang et al. 2009). No KS orthologs or currently known downstream targets
of CND-1 were found in the dataset.
On a transcript level, there are several instances of genes with multiple isoforms that
have differential expression on the isoform level (Table 8). In order to better filter the results, a
more stringent Q-value of 0.01 was used to get a list of isoforms that may be differentially
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expressed. Of the 19 different genes, 18 of them are neuronally expressed in the same
expression clusters as cnd-1.
Up-regulated Transcripts

Down-regulated Transcripts

Gene (Isoform)

Fold Change

Q-value

Gene (Isoform)

Fold Change

Q-value

C27D8.3 (a)

8.113

1.23E-06

C17E7.9 (a)

0.029

1.18E-26

ckc-1 (b)

3.342

5.43E-03

C53B4.4 (e)

0.266

7.37E-03

daf-4 (d)

11.503

2.22E-10

eat-17 (e)

0.177

1.77E-05

ddx-17 (b)

5.986

4.49E-09

nmtn-1 (a.1)

0.143

1.47E-05

dex-1 (c)

2.612

1.60E-06

npp-9 (a.2)

0.011

8.35E-44

eat-17 (a)

101.383

4.73E-48

npp-9 (b.2)

0.023

7.31E-31

F53H2.3 (b)

111.435

8.04E-51

pkc-2 (d)

0.239

3.51E-03

F55A11.6 (b)

4.586

5.24E-03

ppm-1 (c.3)

0.208

2.38E-03

gfi-2 (a.3)

5.950

1.57E-04

ppm-1 (c.2)

0.225

6.64E-03

gls-1 (c)

3.279

3.24E-04

rnp-6 (c)

0.149

6.06E-06

hda-6 (d)

5.915

1.18E-04

rpom-1 (b)

0.201

7.39E-06

ketn-1 (b)

4.347

9.32E-03

srw-85 (b)

0.029

3.00E-25

lea-1 (k)

3.308

3.73E-05

srw-85 (c)

0.089

2.55E-09

pmk-2 (c)

7.906

7.42E-09

srw-85 (d)

0.099

1.55E-08

pmk-2 (d)

5.948

2.23E-05

unc-16 (b)

0.360

1.55E-04

ral-1 (a)

3.081

2.96E-04

unc-43 (p)

0.271

8.38E-03

ZK20.4 (a.2)

0.040

1.07E-20

rnp-6 (a)

127.869

1.26E-54

rpl-1 (b.3)

8.374

2.86E-08

rpl-1 (b.6)

6.716

1.99E-06

sphk-1 (c)

2.606

5.24E-03

unc-43 (g.1)

8.610

1.85E-14

unc-43 (d.1)
6.434
6.46E-11
Table 8. Differential expression of isoforms in the cnd-1 (ju29) transcriptome sorted by a q-value of less than 0.01. The q-value
reported is an adjusted p-value for multiple corrections, also known as a false discovery rate.
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Discussion
Relationship of CND-1 and kal-1
While transcriptional control of kal-1 can be viewed with a perturbation analysis of
reporters, the co-expression assay demonstrates cell-autonomous control of expression. This
indicates that it is likely that CND-1 directly controls kal-1 gene transcription. The expression
profile indicates that cnd-1 does not control kal-1 expression in all co-expressed cells; instead,
variable control is exercised in the anterior pocket region of kal-1 expression. This implies a
more complex control network for the interaction between CND-1 and the kal-1 gene.
On a functionality standpoint, cnd-1 (ju29) mutants cause synergistic embryonic lethality
with efn-4 (bx80) mutants like kal-1 but do not cause increased gastrulation cleft durations.
Instead, the duration of the cleft slightly decreases from wild type embryos, which could
indicate that the synergistic lethality of cnd-1 efn-4 mutants is not due to roles in gastrulation,
but rather some other functionality. As CND-1 acts as a transcription factor, it is entirely
possible that its effect on gastrulation comes from targets other than kal-1. From the
transcriptome, the fkb-8 and sphk-1 genes are potentially differentially expressed and are
known orthologs of ventral tube enclosure genes in mice (Harris and Juriloff 2006). As for the
embryonic lethality assay, the synergistic lethality may or may not be due to a relation with kal1; however, if it was, one would expect less lethality due to the small subset of kal-1 cells that
CND-1 controls.
As a kal-1 regulator, it is difficult to predict which additional genes (if any) may be
involved in the CND-1 control of kal-1. The transcriptome did not identify any transcription
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factors with known binding sites in the kal-1 promoter that might be involved. Thus, continued
experimentation is required in order to determine other interactions in the regulatory network.
Transcriptomics of cnd-1(ju29)
The transcriptome of cnd-1(ju29) provides a small list of differentially expressed gene to
compare. This is most likely due to the noise of the data from the fact that the embryos were at
a variety of stages in development. In addition, the transcriptome is of the whole embryo and
not enriched for cnd-1 cells in any way. This means it is likely that only genes with the largest
differences in transcript level appear in the differential expression dataset. One expectation
would be that unc-3, unc-4, and unc-30 would all appear in the transcriptome since they are
known targets of CND-1. However, this is unlikely in hindsight since CND-1 regulation of those
genes was reported to have both ectopic expression in some cells and reduced expression in
others, meaning that a whole animal transcriptome might not find an overall difference (Hallam
et al. 2000). The relatively small proportion of kal-1 cells under the control of CND-1 is most
likely why kal-1 did not appear in the transcriptome either.
As for genes with q-values less than 0.05, many of them have little information on their
function. One gene that stands out is srw-85 which codes for a G protein-coupled receptor and
is an ortholog of GPR142 and GRP139 in humans. In mouse pancreatic islets, GPR142 is required
for insulin secretion and agonists of the protein are used for diabetes treatments (Wang et al.
2016). GRP139 is expressed in the central nervous system with high expression in the pituitary
and has potential roles in food consumption, energy expenditure, and locomotion (Nøhr et al.
2017). In mice, NeuroD1 is required for insulin production in addition to its functions in
neurodevelopment (Itkin-Ansari et al. 2005). While srw-85 has not been well described in C.
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elegans, it is interesting to see strong regulation of a gene whose ortholog is known to function
in similar pathways to NeuroD1 in mice. Additionally, it appears that during embryogenesis only
the B, C, and D isoforms are produced, not the A isoform. Regulation of the gene seems to be
intronic, with predicted binding sites near the second and last exons in the gene. Visualization
of the differential expression can be found in Figure 16.

Figure 16. Coverage visualization of srw-85 in N2 and cnd-1(ju29) backgrounds. The top track indicates the structure of the srw85 gene with individual isoforms labeled A-D. The red exon is another gene unrelated to srw-85. The two coverage tracks below
represent merged bam files of replicates in each group. The bottom track represents predicted cnd-1 E-boxes and the
consensus sequence. Visualization done in the Integrative Genomics Viewer (Robinson et al. 2011; Thorvaldsdóttir et al. 2013).

Transcriptome Insights: Potential Role of CND-1 in Regulating Ubiquitination Genes

Ubiquitination is a post-translational regulatory process involving the intracellular
trafficking or degradation of proteins. The process that allows ubiquitin to affect a target
protein involves several intermediates, including E1 ubiquitin-activating enzymes, E2 ubiquitinconjugating enzymes, and E3 ubiquitin-protein ligases. Some E3 complexes, known as SKP-1CUL-1-F-box complexes (SCF), involve the use of F-box proteins as adaptors to bind to the target
protein. While humans have approximately 69 F-box proteins, C. elegans has approximately 520
with many being nematode specific (Bakowski et al. 2014).
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From the transcriptome, several genes from this system were differentially expressed in
the cnd-1(ju29) background. Of the 10 F-box genes found, 7 of them are expressed in the
nervous system while the E2 gene ubc-7 and E3 genes T22C1.1, Y105E8A.14 and F07B7.12 were
all neuronally expressed (Table 9). Unfortunately, little is known about these genes with the
exception of the F-box A genes. According to a study done by Aarino et al. (2014) fbxa-191 and
fbxa-192 are under-expressed in the ahr-1 loss-of-function transcriptome. ahr-1 is a
transcription factor involved in neuronal development including cell migration and axon
branching (Qin and Powell-Coffman 2004). While the cnd-1(ju29) transcriptome does not
indicate the roles of these downstream ubiquitination genes, it does suggest that ubiquitination
may be part of the gene regulatory network in which cnd-1 is involved in.
Function

F-box

Ubiquitin-Protein Genes

Gene

Fold Change

F22E5.20

0.469

cnd-1 Co-Neuronal
Clustering
N

fbxb-41*

2.441

Y

fbxb-47

1.700

Y

fbxb-75

2.336

N

fbxb-88

1.655

Y

fbxb-98

0.558

Y

fbxa-191*

0.299

N

fbxa-192*

0.410

Y

fbxb-111*

0.395

Y

mfb-1

1.646

Y

F07B7.12

1.717

Y

T22C1.1

2.094

Y

ubc-7

1.897

Y

Y105E8A.14

1.737

Y

Table 9. List of genes from the differential gene expression data involved in the ubiquitination pathway. Genes are sorted with a
p-value of less than 0.01 and those with a q-value of less than 0.05 are indicated with an asterisk. Neuronal expression is
defined as clustering to one of the neuronal clusters cnd-1 is found in (WBPaper00048988:neuron_expressed or
WBPaper00037950:glr-1(+)-neurons_expressed).
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Transcriptome Insights: Regulation of Synaptic Vesicles

Synaptic vesicles play an important role in neuronal signaling by storing and transporting
neurotransmitters. In addition, they are associated with having an important role in axon
regrowth and repair, though the exact mechanism remains unclear (Chen et al. 2011). Within
the cnd-1 transcriptome, four genes were found to be involved in this process: unc-57, sphk-1c,
cab-1, and unc-16b. cnd-1 is known to control the cell fate and axon outgrowth of DD motor
neurons, which undergo remodeling to remove their connections to ventral muscles and
establish synapses at dorsal muscles during the molt to a stage 2 larva (Hallam et al. 2000). The
inability of cnd-1 loss-of-function worms to move backwards without high degrees of coiling has
been hypothesized to be due to a loss of function in these motor neurons as they undergo
remodeling (Biscevic 2014). Because synaptic vesicle regulation has previously been linked to
DD remodeling under the control of cdk-5 and unc-104, it makes it a likely candidate for cnd-1
control of DD motor neuron remodeling (Park et al. 2011). Since NeuroD1 is a regulator of
several genes associated with KS, a disease involving improper neural connections, it is helpful
to explore how cnd-1 does this task in a model organism.
The influence of synaptic vesicles on axon remodeling has been postulated to occur for a
number of reasons, though two possibilities include transport of injury signals and the addition
of the lipid membrane to the axon in the process of axon extension (Tuck and Cavalli 2010).
Experimentally, loss-of-function mutations in genes like unc-57 and sphk-1 result in reduced or
abnormal axon regeneration indicating that these genes have some influence on this process
(Chen et al. 2011). cab-1 has been identified to interact with aex-3 to activate rab-3, which is
required for normal pioneer axon navigation (Bhat and Hutter 2016). An RNAi screen also
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identified unc-16 as a potential repressor of axon regeneration and implied an interaction with
jnk-1 (Nix et al. 2014). Thus, in some form or another, each of the four genes has been
demonstrated to influence axon regeneration as a synaptic vesicle regulator.
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Chapter 4 – CND-1 Binding Sites in the kal-1 Regulatory Region: Initiating a New Direction
Introduction
Based on the co-expression assay in chapter 3, one can conclude that CND-1 regulation
of kal-1 is cell autonomous. However, it is entirely possible that this regulation requires an
intermediate transcription factor that directly binds to the kal-1 promoter. Three predicted Ebox binding sites for CND-1 exist within the 5.27kb regulatory region, implying that directed
binding of CND-1 to the kal-1 promoter is possible. The molecular nature of this regulation is
critical to understand how it might interact with potential co-factors in regulating gene
expression. In this chapter the foundational efforts in examining direct CND-1 binding are
described, although the work is far from complete.
As previously mentioned, basic helix-loop-helix proteins are transcription factors that
need to dimerize in order to bind to DNA. The dimers typically bind to 6bp E-box sites with each
monomer binding to half of the site (Smith and Matthews 2016). While the binding structure of
CND-1/HLH-2 has not been studied in depth specifically, its orthologs in mammals,
NeuroD1/E47, have. A study by Longo et al. (2008) demonstrated that NeuroD1 homodimers
are thermodynamically unstable and that heterodimers with E47 are preferred. The
interactions of NeuroD1 is not limited to E47 alone, as a study by Ray and Leiter (2007)
indicated that NeuroD1 physically interacts with Sp1, a transcription factor that acts as a
secretin gene enhancer, in order to stabilize its binding to DNA to activate transcription. While
an interaction between CND-1 and SPTF-3, the C. elegans ortholog of Sp1, has not been
established, it is known that CND-1 can interact with other proteins (Figure 10). While it is not
known what the binding relationship might be in vivo, there is a possibility that CND-1/HLH-2
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heterodimers may only be part of the complex required to activate gene expression as seen in
chapter 3.
The promoter deletion assay in chapter 2 revealed tissue-specific control of different cisregulatory regions. Each of the reporters in the assay excluded a CND-1 E-box, allowing for an
estimation with which areas of the promoter CND-1 may be interacting. When embryonic
expression of the reporter constructs is compared, none of them contain the GFP expressing
cells under the control of CND-1. Figure 17 describes the embryonic results from the promoter
deletion assay.

Figure 17. Representative view of embryonic GFP expression in Reporter A. The green arrows represent the locations of CND1/HLH-2 E-boxes along the promoter. Time-lapse data is representative of Reporter A GFP expression during embryogenesis.
The time given is approximate minutes into development.
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Based on this observation, it is hypothesized that CND-1/HLH-2 directly binds to an Ebox in order to control expression of the kal-1 reporter. In order to determine if these sites are
utilized for kal-1 regulation, three questions need to be addressed: can CND-1/HLH-2 bind to
these specific E-boxes given their genomic flanking sequences, what tissue-specific expression
do the E-boxes control, and are they required for GFP expression in cells under the control of
CND-1? From observations represented by Figure 17, it is predicted that E-box 1 is most likely
utilized due to it being contained in a region sufficient for GFP expression of cells under the
control of CND-1.
The most pertinent concept to address is the ability of CND-1/HLH-2 to bind to these
specific E-boxes in the first place. While the Grove et al. (2009) paper elucidated the specific
sites, it is important to take into account that these sites act in the context of the flanking
sequences. Research from Gordan et al. (2013), indicates that the flanking sequence of E-box
sites can strongly influence the binding affinity of bHLH proteins, especially the first 2 flanking
bases. One method of addressing this is to perform an electrophoretic mobility shift assay
(EMSA) with probes that include flanking sequences. This works by running DNA on a native gel
with increasing concentrations of the protein complex. If the protein binds to the DNA, it should
run slower due to the increased weight and “shift” up the gel. EMSAs have successfully been
used in several studies on NeuroD1 transcriptional regulation (Breslin et al. 2003; Poulin et al.
1997; Cherrington et al. 2008).
After ascertaining the binding affinity of CND-1/HLH-2 to the E-boxes, one can follow-up
by analyzing the regulatory roles of the sites themselves. Verified binding sites that
demonstrate overlapping expression patterns to the effects of cnd-1 loss-of-function would

52

suggest a direct interaction. Previously, transgenic GFP reporters were used in order to
ascertain which parts of the 5.27kb regulatory region controlled expression in which tissues.
Using the same approach for smaller regions surrounding target E-boxes, it is possible to
address if these regions are sufficient to control GFP expression. Because the regulation of
transcription often involves multiple factors, it also indicates if E-boxes work autonomously to
regulate transcription or if they require other sites within the 5.27kb regulatory region.
In order to determine if the E-box itself is required for transcription in the context of the
regulatory region, a site-directed mutagenesis approach would be ideal. By removing only the
E-box, the rest of the regulatory mechanisms are maintained that may be required. In addition,
one could compare findings from this data to E-box reporters to determine if their regulatory
effects are dependent on nearby sites. These assays will not only illuminate the molecular role
of CND-1 in kal-1 regulation, they will also ascertain the importance of the E-box sites
independent of CND-1.
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Methods
CND-1 and HLH-2 Bacterial Transformation and Restriction Enzyme Digest
Coding sequences for CND-1 and HLH-2 were synthesized using overlapping
oligonucleotides by GENEWIZ into pET28A(+) vectors and codon-optimized for E.coli expression.
For each vector, competent DH5α and BL21(DE3)pLysS cells were used for long-term storage
and expression experiments, respectively. Cells were thawed on ice for 30 minutes.
Approximately 1ng of vector was mixed with 50µl of competent cells in a micro centrifuge tube
and placed on ice for 30 minutes. Samples were heat shocked by placing them in a 42oC water
bath for 60 seconds and then placing them on ice for 2 minutes. 500µl of LB media was added
to samples which were then placed in a shaking incubator for 45 minutes. The samples were
then plated onto kanamycin agar plates and left to grow overnight at 37oC.
From the bacterial colonies that grew, one from each plate was sampled and placed into
3ml of LB media with kanamycin and incubated at 37oC. Aliquots of 1ml were stored in 50%
glycerol at -80oC. A Zippy™ Plasmid Miniprep Kit from Zymo Research was used to isolate
vectors with the methodology following the instructions from the manufacturer. This was
followed by a restriction enzyme digest in order to verify the identity of vectors in the
transformed samples.
Induction of Target Protein Production
Frozen transformed cells were sampled and placed in 3ml of LB media with a 1:1000
dilution of kanamycin and incubated at 37oC overnight. A 1ml aliquot was mixed with 50ml of
LB media with antibody and incubated at 200rpm and 37oC until the OD600 of the media was
0.4. Afterwards, isopropyl β-D-1-thiogalactopyranoside (IPTG) was added (0.5mM final
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concentration) and the culture was incubated for an additional three hours. Samples were
centrifuged at 4000rpm and the pellets were stored in a -80oC freezer.
Protein Purification
Proteins were purified using Invitrogen Dynabeads His-tag Isolation and Pulldown
following manufacturer’s instructions. Cell lysate was prepared by thawing frozen pellets in
700µl of wash buffer (500mM Sodium Phosphate, pH 8.0, 300mM NaCl, 0.01% Tween-20) and
sonicating in 10 second pulses four times using a Misonix Microson XL sonicator at 3 watts. All
subsequent steps were performed in a cold room at 4oC. The cell lysate and Dynabeads were
incubated for 20 minutes and four subsequent washes were performed with wash buffer.
Afterwards, 60µl of His-Elution buffer (300mM Imidazole, 50mM Sodium Phosphate pH 8.0,
300mM NaCl, 0.01% Tween-20) was used to elute the solution. Solutions were stored with an
addition of 50% glycerol at -20oC. For CND-1 purification, additional trials of this protocol were
attempted in 7M urea-containing versions of the above solutions with an additional dialysis
step using Slide-a-lyzer mini cassettes and dialysis buffer (10mM HEPES pH 7.4, 0.15M NaCl,
1mM CaCl2, 10% glycerol, 1mM DTT). Protein composition of solutions was verified via SDSPAGE and Coomassie blue staining.
Western Blot detection of 6His-CND-1 and 6His-HLH-2
Cellular lysate was prepared via a freeze-thaw method and run on a 15% SDS-PAGE gel.
After transferring the protein to a membrane and confirming using Ponceau S staining, the
membrane was blocked using a 5% non-fat milk solution overnight at 4oC. The next day, the
membrane was incubated in a 1:2000 dilution of Abcam Anti-6X His tag® antibody (ab1187)
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overnight at 4oC. After three washes with TBST it was incubated with SuperSignal™ West Pico
Chemiluminescent Substrate and imaged with a ChemiDoc™ XRS+.
Electrophoretic Mobility Shift Assay
Fluorescence-labeled DNA probes were ordered from Integrated DNA Technologies and
are listed in Table 10. An Odyssey® Infrared EMSA Kit was used and manufacturer’s guidelines
were followed. Oligonucleotides were annealed by mixing them in equal concentrations and
heating them at 100oC for five minutes and letting them slowly cool down by turning off the
dry-bath. Reaction mixtures were prepared as recommended by the sample IR-EMSA binding
reaction in Table 1 of the manual with no optional components and a protein concentration of
1000nM (Odyssey® Infrared EMSA Kit 2012). Reaction mixtures were loaded into a 10% native
TBE gel with 0.5x TBE running buffer. Samples were run for five minutes at 5V/cm and then for
one hour at 10V/cm. Gels were imaged on a Li-Cor Odyssey Infrared Imaging System.
Name
Oligonucleotide sequence
Scale
Purification Method 5’ modification
Ebox1F
AGTCCGAAACATCTGTCAAGGCCC
100nmol
HPLC
5IRD700
Ebox1R
GGGCCTTGACAGATGTTTCGGACT
100nmol
desalted
none
Ebox2F
ACCCCCAAACATCTGTACTAGTCC
100nmol
HPLC
5IRD700
Ebox2R
GGACTAGTACAGATGTTTGGGGGT
100nmol
desalted
none
Ebox3F
TCGATGCACCATATGTGGGTCATT
100nmol
HPLC
5IRD700
Ebox3R
AATGACCCACATATGGTGCATCGA
100nmol
desalted
none
Table 10. DNA probes to be tested for CND-1/HLH-2 binding using EMSA. Each set has a IRD700 red fluorescent tag that is
compatible with the Li-Cor Oddyssey Infrared Imaging System.

E-box Reporters
Primers for the GFP reporters of the E-boxes are listed in Table 11. Those for E-boxes 1
and 2 are in development while E-box 3 is built. PCR amplification of the fragment were
performed as in chapter 1. Cloning was done using a pCR8™/GW/TOPO® TA Cloning® Kit
following manufacturer’s guidelines. The amplified fragment was inserted into the pCR8-TOPO
entry vector and transformed into One Shot® TOP10 cells and plated on Spectinomycin plates
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overnight. A restriction digest was performed to verify the transformation. The final vector for
injection was prepared by recombining the entry clonal vector with the pCZGY32 destination
vector, TE buffer and LR Clonase II Enzyme Mix and incubated for one hour at 25oC. Proteinase
K was used to terminate the reaction and the new vectors were transformed into One Shot®
TOP10 cells and plated onto Ampicillin plates. The recombinant plasmids were verified with a
restriction enzyme digest. Injections were performed as in chapter 1.
Transgenic
Annealing Time Co-injection
Forward Primer
Reverse Primer
Strain
(seconds)
Marker
Reporter E.1 (P) TGCTTCCCCTTTTCATTTTG
TGGGCCAAAATTTAGGAATG
TBD
pCoel::GFP
Reporter E.2 (P) GTTCCCGATTTGTGAGCTGT
CTGGGGGTAGTGTTTTTGGA
TBD
pCoel::GFP
Reporter E.3 TGAGTTACTTGATGCAC
CATTGATTAACACGGTG
15
pCoel::GFP
Table 11. Reporter constructs for CND-1/HLH-2 E-boxes. Transgenic strains with a “(P)” indicate a proposed reporter not yet
constructed. Annealing time for strains undergoing construction are listed as “TBD” indicating they are still to be determined.
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Preliminary Results and Discussion
Work on the protein purification and EMSA assays is ongoing. Currently, protein
purification of both CND-1 and HLH-2 works with sporadic success though they cannot be
verified as functional through EMSAs. The purification of CND-1 seems to require denaturation
as none of the trials without 7M urea were successful. HLH-2, on the other hand, does not
require denaturation and can be purified on its own using Dynabeads. Western blotting
confirms the presence of CND-1 and HLH-2 production (Figure 18).

Figure 18. Verification of CND-1 (21.8kD) and HLH-2 (43.2kD) production. A) Coomassie blue stain of SDS-Page gel covering the
purification of CND-1 without denaturing. The black arrows point to bands representing CND-1. B) Same assay as A but done
with 7M urea. Black arrows also indicate bands representing CND-1, including the band present in the elution lane here but not
in A. C) SDS-Page gel outlining the purification of HLH-2 without denaturing. Black arrows point to bands representing HLH-2. D)
Western Blot of 6x His-tagged proteins. The white arrows point to bands at the proper molecular weight for HLH-2 and CND-1.

Pilot EMSAs showed no shift in band position, suggesting that the proteins were not
binding to the DNA (Figure 19). E-box 3 was used in the pilots since it has the highest binding
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affinity for the dimer indicated by Grove et al. (2009). One possibility is that CND-1 is not
refolding properly in the dialysis step. Multiple purifications have been tried with little success
in verifying functionality. Previous studies analyzed the E47/NeuroD1 heterodimer by coexpressing the two proteins and in the case of Longo et al. (2008) removing the His-tag prior to
the EMSA (Breslin et al. 2003). This suggests that CND-1 might be purified as a CND-1/HLH-2
heterodimer without denaturation, which would bypass the potential refolding issue.

Figure 19. EMSA of Ebox-3 using CND-1, HLH-2, and CND-1/HLH-2. Intensity of the fluorescence is greatly amplified to
demonstrate the lack of shifting. The bottom row of primers indicates primers that were not annealed while the top row shows
unbound dual-stranded DNA probes.

Out of the E-box reporter assay, only E.3 has been fully constructed and analyzed.
Reporter E.3 consists of a 380bp section of the otIs33 promoter that encompasses the third Ebox. These transgenic animals only show GFP expression from the coelomocyte co-injection
marker, suggesting that Reporter E.3 is not sufficient to drive GFP expression (Figure 20).
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Figure 20. GFP expression in a Reporter E.3 L1 worm. The GFP coelomocyte co-injection marker can be seen but no other GFP
expression is reported.

Lack of GFP expression in Reporter E.3 does not rule out that this E-box is functional, but
it does suggest it is likely not under control of CND-1. It is possible that CND-1/HLH-2 could bind
to this site and be required to interact with another transcription factor in the 5.27kb region to
regulate expression. This possibility could be tested with a reporter strain built using sitedirected deletion of the third E-box. When taken in the context of the promoter deletion assay,
it does suggest that this region does not have enhancer sites for kal-1 tissues.
From observations made using the promoter deletion assay in Figure 17, it is predicted
that Reporter E.1 should drive GFP expression. The known example of NeuroD1/E47 interaction
with Sp1 gives precedence of interacting with neighboring binding sites, which is taken into
account by the size of the reporters. From that paper (Ray and Leiter 2007), it was shown that
NeuroD1 enhanced the stability of another transcription factor, and its loss of function caused
an incomplete penetrance in loss of gene expression. The outcome of this example is similar to
the incomplete penetrance seen in CND-1 affecting kal-1 expression. Using a Cis-BP database
(Weirauch et al. 2014) search, only E-box 1 has a similar situation in that an unc-62 predicted
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binding site overlaps with the CND-1/HLH-2 site. As shown in Figure 10, unc-62 has the ability to
bind to CND-1, which means there is a possibility of a similar situation to that of NeuroD1 and
Sp1. Investigating if unc-62 regulates kal-1 transcription would be something of interest.
These ongoing assays should explain if the regulation of kal-1 by CND-1 is direct via one
of the predicted E-boxes. In the event that there is no evidence suggesting a direct interaction,
it is likely that there is an intermediate transcription factor that is under the control of CND-1.
This transcription factor is unlikely to be ubiquitously regulated by CND-1 during embryogenesis
as few were found to be differentially expressed in the cnd-1(ju29) transcriptome. Finding
potential intermediates would be challenging, but one possibility is to dissociate otIs33
stIs10055 embryos, sort for co-expressed cells, and use single cell RNA-seq to determine what
transcription factors are enriched in that population. Alternatively, one could do an RNAi screen
of predicted transcription factors downstream of cnd-1 based on the transcriptome and see if
they affect kal-1 reporter expression.
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Chapter 5 - Conclusions
This thesis provides two main avenues to pursue for future work: the transcription
factors involved in kal-1 regulation and understanding the downstream targets of cnd-1 as a
potential KS gene in its own right. The foundations for understanding kal-1 regulation are
already made in the form of a comprehensive expression pattern and a map of kal-1 control
elements in the 5.27kb upstream region. While having one transcription factor regulating kal-1
is a success, the new data from the other assays allows for more informed predictions.
Potentially, a good way to go about this quickly would be to do a RNAi screen in a Punc-119::
sid-1 (+) background. The promoter for unc-119 is considered to be ubiquitously expressed
throughout the nervous system and when sid-1 is overexpressed, neurons become more
susceptible to RNAi (Calixto et al. 2010). This would allow for a larger screen where genes that
show differential GFP expression could be followed up with proper loss-of-function strains
being tested.
While the kal-1 gene was explored in the context of the otIs33 GFP reporter, it is
imperative to understand that regulatory mechanisms are not limited to this region. Often
times, regulation in nematodes rely on binding sites found within the first intron of the gene. It
is thought that this trend is possibly due to the large amount of genes in nematodes compared
to the size of the genome. For reference, the C. elegans genome is around 100Mb and contains
over 19,000 genes whereas the human genome is 3.3Gb and contains approximately the same
amount (Hiller et al. 2005; Ezkurdia et al. 2014). The first intron in eukaryotic organisms
typically shows high conservation which positively correlates to its number of transcription
factor binding sites and other regulatory mechanisms (Park et al. 2014). C. elegans also
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typically have larger first introns, 74bp versus 54bp on average, and they were found to contain
50% more interactive binding sites with TFs than other introns (Bass et al. 2013). Therefore,
intronic regulation of gene expression is an important consideration and a future direction of
the project.
The major insights into kal-1 expression patterns was due to embryonic lineaging. An
issue with the promoter deletion assay was that it is limited to only those neurons which can
most easily be identified in order to reduce false positives. While lineaging these promoters is
not logistically convenient due to the chimeric nature of an extrachromosomal array, it would
provide a comprehensive solution using integrated reporter lines. This would take a significant
time investment but the amount of data gathered through a lineaged promoter deletion assay
would provide cell-specific details.
While cnd-1 has been shown to regulate kal-1 gene expression, it is not clear if this
regulation is due to direct binding of CND-1 to the promoter region or from an intermediate
transcription factor that CND-1 affects. Ongoing assays outlined in chapter 4 investigate this
role by determining if CND-1 can bind to predicted sites and if those sites are necessary for
expression in cells under the control of CND-1. Defining the regulation of kal-1 on a molecular
level is crucial for understanding the role of specific regulators.
The second avenue is the study of downstream targets and pathways of cnd-1. The main
problem with the data collection was the noise in the transcriptome data. One potential
solution to this would be adding additional replicates to analyze. Using the power prediction
program Scotty, only one additional replicate per group seems to be required to achieve 50% of
genes with a fold change of greater than 2 or less than 0.5 being statistically significant (Busby
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et al. 2013). However, even with additional replicates, it is unclear how tangible the benefits
would be since a mixed stage embryonic transciptome is inherently noisy. Another method of
getting more statistically powerful data would be to analyze the transcriptome of L1 larvae
instead of embryos. This would allow for consistent staging of large quantities of animals for
RNA extraction and should reduce the noise found in the current mixed embryonic stage
dataset. In addition, it may reveal downstream targets involved in the abnormal axon growth
found in cnd-1 loss of function mutants. A downside to this alternative would be that it doesn’t
address potential intermediates in the embryonic interaction between CND-1 and kal-1.
Even without a more statistically powerful transcriptome, the data suggests prospective
avenues in the form of downstream ubiquitination and synaptic vesicle pathways under cnd-1
control. Exploring these in C. elegans may give clues about NeuroD1 regulation in other
organisms. This data will act as a foundation for future projects investigating the role of a
critical transcription factor in neuronal cell fate and potentially the KS disease system.
In conclusion, the investigation of this thesis provides an expanded understanding into
the expression patterns and cis-regulatory architecture of kal-1 in C. elegans. From this data,
better informed predictions can be made about potential regulators of kal-1 and directions to
explore in understanding what turns kal-1 on and off in different tissues at different stages of
life. The investigation into upstream transcription factors has yielded cnd-1 as a potential kal-1
regulator which interestingly enough has demonstrated regulatory functions of other KS genes
in mice. By analyzing the genomic effects of cnd-1, this thesis brings new avenues of study to
understanding its role in development. Thus, while a solid foundation has been laid, there is still
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much on which to follow-up in exploring the regulation of kal-1 and the regulatory effects of
cnd-1.
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Integrative Biology Statement
This thesis consists of tools and assays from a span of biological disciplines in order to
answer questions from a molecular to an organismal scale. On a molecular level it addresses
the cis-regulatory architecture of kal-1 through promoter deletion analysis and explores how
the transcription factor CND-1 interacts with it. It puts kal-1 into a developmental context by
quantifying expression throughout embryogenesis and giving a comprehensive assessment of
which parts of the animal express the gene through embryonic lineaging. The interaction
between CND-1 and kal-1 is put into a functional context through phenotypic assays such as
embryonic lethality and gastrulation. The transcriptional role of cnd-1 is put into a whole
organism context through the transcriptome analysis. The project spans multiple disciplines of
biology, including: genetics, molecular biology, developmental biology, and computational
biology. Finally, the project itself was carried out in an integrative spirit by working with
collaborators and advisors inside and outside of Kennesaw State University.
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Supplementary Figures and Tables

Supplementary Figure 1. Expanded view of the P-kal-1-GFP embryonic lineage. Increase in signal intensity is color coded with warmer colors indicating stronger GFP expression.
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Gene
Base Mean
Fold Change
Standard Error
Wald-Stat
P-value
Q-value
B0025.4
42.107
2.087
0.325
3.265
1.09E-03
4.02E-01
B0035.18
39.713
2.086
0.324
3.269
1.08E-03
4.02E-01
C04G6.10
61.786
2.689
0.310
4.597
4.29E-06
4.17E-03
cnc-10
353.609
2.561
0.307
4.417
1.00E-05
8.02E-03
cnd-1
811.714
1.782
0.320
2.607
9.14E-03
1.00E+00
dhs-24
1240.011
1.895
0.238
3.879
1.05E-04
6.22E-02
dmd-6
4708.669
1.708
0.281
2.753
5.91E-03
1.00E+00
emo-1
3415.667
1.599
0.258
2.624
8.70E-03
1.00E+00
F07B7.12
2607.317
1.717
0.262
2.978
2.90E-03
8.45E-01
F13E9.15
28.093
2.552
0.305
4.429
9.48E-06
7.92E-03
F14F11.2
145.923
2.126
0.324
3.357
7.88E-04
3.29E-01
F26E4.4
1079.029
2.719
0.294
4.899
9.62E-07
1.11E-03
F33E2.5
1880.435
2.632
0.313
4.465
7.99E-06
7.35E-03
F35B3.3
39.266
5.010
0.323
7.198
6.10E-13
1.40E-09
fbxb-41
488.606
2.441
0.304
4.231
2.33E-05
1.65E-02
fbxb-47
24.946
1.700
0.271
2.829
4.67E-03
1.00E+00
fbxb-75
193.815
2.336
0.324
3.782
1.56E-04
8.69E-02
fbxb-88
256.942
1.655
0.255
2.847
4.41E-03
1.00E+00
har-1
1840.270
1.735
0.305
2.603
9.25E-03
1.00E+00
K11H12.1
640.995
1.864
0.324
2.772
5.57E-03
1.00E+00
lgc-34
1194.076
4.649
0.281
7.878
3.33E-15
8.74E-12
mfb-1
1271.101
1.646
0.268
2.685
7.26E-03
1.00E+00
moa-2
385.979
2.029
0.308
3.318
9.07E-04
3.55E-01
mrps-10
450.427
1.683
0.291
2.580
9.89E-03
1.00E+00
nhr-25
2876.395
1.596
0.230
2.937
3.31E-03
9.09E-01
R13H4.8
151.372
1.896
0.323
2.856
4.29E-03
1.00E+00
rpb-11
598.265
2.046
0.325
3.183
1.46E-03
5.06E-01
rpc-11
67.879
1.714
0.280
2.776
5.50E-03
1.00E+00
rpl-38
651.445
31.538
0.272
18.338
4.09E-75
7.53E-71
T01D1.4
3764.852
1.587
0.236
2.825
4.73E-03
1.00E+00
T20G5.8
122.007
2.015
0.309
3.277
1.05E-03
4.02E-01
T22C1.1
3306.543
2.094
0.278
3.829
1.28E-04
7.38E-02
ttr-8
18.645
1.820
0.287
3.012
2.59E-03
7.70E-01
ubc-7
5620.945
1.897
0.301
3.065
2.17E-03
6.78E-01
unc-57
2135.359
1.856
0.249
3.580
3.44E-04
1.62E-01
Y105E8A.14
106.725
1.737
0.306
2.598
9.36E-03
1.00E+00
Y48C3A.18
338.956
1.924
0.253
3.728
1.93E-04
9.85E-02
Y57E12AR.1
137.866
2.662
0.318
4.439
9.05E-06
7.92E-03
zig-1
2475.886
1.606
0.225
3.037
2.39E-03
7.32E-01
ZK1010.10
77.326
2.221
0.313
3.678
2.35E-04
1.17E-01
ZK512.11
136.817
2.277
0.303
3.914
9.06E-05
5.59E-02
ZK686.1
940.662
2.143
0.281
3.913
9.12E-05
5.59E-02
Supplementary Table 1. List of up-regulated genes with a 1.5-fold change or greater from the cnd-1(ju29) transcriptome with a
p-value of less than 0.01. Genes are sorted in alphabetical order.
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Gene
abhd-5.1
abu-8
anr-39
C06B3.6
C08F11.7
C15H11.11
C18H2.3
C28C12.4
C33E10.4
C33H5.8
C47G2.7
C55C3.3
cab-1
col-12
col-160
col-181
crb-3
cyp-34A9
F09G8.7
F22E5.20
F34H10.3
F35B3.4
F53F4.2
F55A11.7
fbxa-191
fbxa-192
fbxb-111
fbxb-98
fipr-13
fkb-8
glb-1
gsp-1
H14A12.5
his-67
hlh-15
K05F6.12
linc-15
lys-1
nlp-37
pqn-88
R02F11.1
R09E10.13
srw-85
T03F6.10
trpp-5
ttr-33
tts-1
Y102A5C.5
Y106G6D.6
Y43C5A.7
Y51H4A.8
Y53F4B.26
Y60C6A.1
Y65B4BL.7
Y66D12A.19
Y82E9BR.22

Base Mean
89.031
2414.792
7.201
519.846
43.608
11.879
119.280
55.477
37.019
89.649
23.514
65.126
3812.030
774.406
902.875
38.898
359.913
81.093
37.847
230.406
964.528
173.993
24.018
462.724
26.768
223.967
122.289
63.455
68.182
475.717
4865.912
7495.640
22.454
23.594
10.497
118.726
37.628
1474.074
269.488
18.183
5462.087
262.860
368.618
16.439
445.466
192.462
1528.776
56.273
72.457
96.427
108.527
10.742
61.243
87.054
247.488
231.742

Fold Change
0.579
0.466
0.492
0.559
0.252
0.579
0.106
0.507
0.213
0.587
0.224
0.522
0.610
0.553
0.547
0.529
0.486
0.514
0.151
0.469
0.472
0.067
0.506
0.621
0.299
0.410
0.395
0.558
0.489
0.572
0.178
0.604
0.550
0.234
0.625
0.314
0.430
0.543
0.578
0.579
0.541
0.509
0.158
0.356
0.555
0.348
0.472
0.306
0.431
0.545
0.556
0.442
0.556
0.524
0.480
0.415

Standard Error
0.294
0.318
0.292
0.325
0.320
0.299
0.314
0.325
0.324
0.298
0.325
0.302
0.259
0.320
0.318
0.310
0.323
0.305
0.322
0.299
0.316
0.315
0.311
0.232
0.322
0.301
0.307
0.294
0.317
0.241
0.316
0.245
0.325
0.324
0.257
0.324
0.325
0.324
0.291
0.288
0.280
0.312
0.312
0.324
0.296
0.322
0.324
0.312
0.323
0.300
0.314
0.300
0.303
0.324
0.309
0.307

Wald-Stat
-2.683
-3.459
-3.510
-2.580
-6.220
-2.643
-10.302
-3.013
-6.874
-2.584
-6.642
-3.106
-2.751
-2.665
-2.743
-2.964
-3.222
-3.145
-8.466
-3.653
-3.426
-12.363
-3.162
-2.968
-5.412
-4.274
-4.363
-2.864
-3.256
-3.338
-7.887
-2.969
-2.654
-6.470
-2.639
-5.160
-3.745
-2.721
-2.721
-2.738
-3.164
-3.119
-8.539
-4.596
-2.868
-4.732
-3.337
-5.470
-3.764
-2.919
-2.699
-3.929
-2.794
-2.878
-3.429
-4.140

P-value
7.30E-03
5.42E-04
4.48E-04
9.87E-03
4.98E-10
8.21E-03
6.89E-25
2.59E-03
6.22E-12
9.77E-03
3.10E-11
1.90E-03
5.95E-03
7.71E-03
6.09E-03
3.03E-03
1.27E-03
1.66E-03
2.53E-17
2.59E-04
6.13E-04
4.14E-35
1.57E-03
3.00E-03
6.24E-08
1.92E-05
1.29E-05
4.18E-03
1.13E-03
8.43E-04
3.10E-15
2.99E-03
7.95E-03
9.81E-11
8.32E-03
2.47E-07
1.80E-04
6.50E-03
6.51E-03
6.18E-03
1.56E-03
1.81E-03
1.36E-17
4.30E-06
4.13E-03
2.23E-06
8.46E-04
4.49E-08
1.67E-04
3.51E-03
6.96E-03
8.54E-05
5.21E-03
4.01E-03
6.05E-04
3.47E-05

Q-value
1.00E+00
2.43E-01
2.06E-01
1.00E+00
7.64E-07
1.00E+00
4.23E-21
7.70E-01
1.27E-08
1.00E+00
5.70E-08
6.02E-01
1.00E+00
1.00E+00
1.00E+00
8.45E-01
4.51E-01
5.45E-01
9.31E-14
1.25E-01
2.62E-01
3.81E-31
5.24E-01
8.45E-01
8.19E-05
1.41E-02
9.85E-03
1.00E+00
4.07E-01
3.38E-01
8.74E-12
8.45E-01
1.00E+00
1.64E-07
1.00E+00
3.03E-04
9.48E-02
1.00E+00
1.00E+00
1.00E+00
5.24E-01
5.85E-01
6.24E-14
4.17E-03
1.00E+00
2.41E-03
3.38E-01
6.36E-05
9.05E-02
9.50E-01
1.00E+00
5.59E-02
1.00E+00
1.00E+00
2.62E-01
2.36E-02

Supplementary Table 2. List of downregulated genes from the cnd-1 (ju29) transcriptome sorted by a p-values of less than 0.01.
Genes are given in alphabetical order.
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